Paxlovid enhances treatment options for COVID-19 patients

Viking Ther­a­peu­tics’ dual GLP-1/GIP re­cep­tor ag­o­nist for obe­si­ty showed off pos­i­tive topline da­ta from a Phase II study, with an­a­lysts de­scrib­ing the drug as a

While planned retirement topped the list of reasons for nurses leaving healthcare, failures by employers also played a role, according to a cross-sectional study that